South Korea: medical and donor requirements
South Korean law sets binding requirements for embryo-producing medical institutions, gamete-donor screening, written consent, prohibited uses of gametes and embryos, egg-retrieval frequency, and limited donor reimbursements. It does not follow that every clinic must accept every intended parent, donor or gestational-carrier arrangement. The safest starting point is to identify which requirement comes from legislation, which is a clinic’s clinical protocol, and which question concerns the separate legal status of surrogacy. This guide focuses on the first two categories and does not decide parentage, citizenship, immigration or the overall enforceability of a surrogacy arrangement.
What the national rules actually regulate
The main sources are the Bioethics and Safety Act and its Enforcement Decree and Enforcement Rule. They regulate embryo creation for pregnancy purposes, designated embryo-producing medical institutions, donor health protection, consent and handling of embryos and gametes. Under Article 23, an embryo may not be created for a purpose other than pregnancy. The same article prohibits certain methods of embryo creation and conditional consideration for providing or using embryos, eggs or sperm. These provisions are important, but they are not a complete code for every medical, contractual or family-law issue that can arise in a surrogacy plan.
Use a properly designated ART institution
A medical institution that retrieves or stores eggs or sperm for in-vitro fertilisation, or fertilises them to create embryos, must have the designation required by Article 22. The institution must also meet prescribed staffing and facility standards. Before paying a deposit or handing over gametes, ask for the institution’s exact legal name and current designation details, and verify them through the relevant Korean authority. A general hospital licence, fertility-clinic advertisement or overseas intermediary’s assurance is not, by itself, proof that the particular institution holds the required designation for embryo creation.
Mandatory health screening for gamete donors
Before retrieving eggs or sperm, the designated institution must arrange the health screening specified in the implementing rules. The current list includes the following tests. Pelvic ultrasound and cervical cytology apply to egg donors only; they are not listed as routine donor tests for sperm providers.
| Required test |
|---|
| ABO/Rh blood typing |
| Complete blood count (CBC) |
| Urinalysis |
| Glucose test |
| Blood creatinine |
| Blood urea nitrogen (BUN) |
| Liver enzymes (SGOT/SGPT) |
| Total bilirubin |
| Hepatitis virus tests (HBsAg, HBsAb, Anti-HCV) |
| Syphilis test (VDRL or RPR) |
| HIV antibody test |
| Pelvic ultrasound — egg donors only |
| Cervical cytology / Pap smear — egg donors only |
What the screening result means
The rules prohibit retrieval from a donor whose results show syphilis, hepatitis, HIV/AIDS or another disease or abnormal finding that makes retrieval medically inappropriate. The institution must inform the donor of the screening results. The legal test list is a minimum statutory framework, not a guarantee that a donor has no genetic condition or that a particular treatment is medically suitable. Ask which additional tests are proposed, why they are recommended, who pays, how results and family history are handled, and whether a negative result has a defined validity period under the clinic’s protocol.
Lifetime limit on egg retrieval
The Enforcement Decree limits egg retrieval from the same donor to three times over her lifetime, with at least six months between retrievals. If a complication occurs, another retrieval cannot take place until six months after the complication has fully resolved. These are legal limits, not merely a clinic preference. The Enforcement Rule also requires the institution to verify the donor’s prior retrieval history before collection and report the retrieval result to the Minister of Health and Welfare under the procedure the Minister prescribes. A donor should disclose previous retrievals and complications accurately; ask the clinic how it verifies and records these steps.
Written consent must come before treatment
Article 24 requires written consent when eggs or sperm are collected to create embryos. The consent rights belong to the gamete donor, the person undergoing IVF treatment and, if any of them has a spouse, that spouse as specified by the Act. Before signing, the institution must explain the relevant matters sufficiently. The form must address the purpose of embryo creation; storage and storage period for embryos, eggs and sperm; disposal; possible research use of surplus embryos and eggs; changing or withdrawing consent; rights and privacy; and the additional matters prescribed by regulation. Consent is not a substitute for confirming that the planned procedure is legally available.
Documents and record retention
Where donor eggs or sperm are used, the implementing rule requires additional documents: evidence confirming the donor’s identity, a family-relations certificate, the prescribed gamete-donation consent form and the prescribed recipient consent form. The ordinary embryo-creation consent form is also required. A separate form applies when gametes are collected and frozen for the purpose of pregnancy. If surplus embryos or eggs are to be used for research, additional research-use consent is required. The institution must retain the relevant consent forms for ten years. Ask for copies of signed forms and written confirmation of how records, stored gametes and embryos will be managed if the institution closes or transfers custody.
Donor reimbursement is narrowly regulated
Article 23 prohibits making the provision or use of embryos, eggs or sperm conditional on money, property benefits or other consideration, and also prohibits inducing or arranging such activity on that basis. Article 27 and Rule 24 allow only specified donor reimbursements. These include transport, meals, lodging and compensation for time spent on the procedure and recovery. Transport, meals and lodging are calculated under the prescribed public-servant travel standard; procedure/recovery compensation is set by the institution head after review by the institutional committee, and the payment is reported to that committee. This is not a general licence to buy gametes or to pay any amount a broker proposes. A gamete-donor reimbursement rule also does not, by itself, authorise payment to a gestational carrier.
Prohibited embryo-creation practices
Article 23 prohibits creating embryos for purposes other than pregnancy. It also prohibits selecting eggs and sperm for fertilisation with the purpose of choosing a particular sex, fertilising with gametes of a deceased person, and fertilising with gametes from a minor. The Act states an exception for a married minor who is conceiving a child of their own. Do not assume that the exception extends to donor use or to other circumstances. The text of the prohibition should be checked against the exact proposed procedure, timing and facts by Korean counsel; it should not be expanded into a claim about every genetic test or laboratory procedure without separate legal support.
Law versus a clinic’s medical policy
A clinic may apply additional criteria, such as age limits for adult donors, ovarian-reserve indicators, medical history, genetic-carrier screening, psychological assessment or rules on which patients it will treat. The provisions summarised here do not establish one universal adult-donor age range or a complete list of clinical eligibility criteria for every programme. Ask the clinic to label each requirement as (1) a statutory or regulatory requirement, (2) a professional standard, (3) the clinic’s own safety protocol, or (4) a commercial or administrative condition. Request the relevant written policy and the legal provision, if one is claimed. A clinic may decline treatment for a reason beyond the minimum statutory screening rules; that does not automatically mean the law itself imposes that same criterion on every clinic.
Surrogacy-specific medical eligibility is a separate question
The donor and embryo rules do not provide a complete statutory medical checklist for a gestational carrier, nor do they by themselves establish that a proposed surrogacy arrangement is permitted, enforceable or capable of producing the intended parentage result. A carrier’s obstetric history, current health, informed consent, independent advice and the proposed embryo-transfer procedure need separate assessment under the law and current medical standards applicable to the actual case. Do not infer that a clinic’s willingness to perform IVF resolves the legality of transferring an embryo to a gestational carrier. Parentage, birth registration, nationality and cross-border recognition require separate analysis and may involve other jurisdictions.
Supreme Court precedent is a separate warning
A directly relevant decision of the Supreme Court of the Republic of Korea must also be considered. On 24 April 2025, in case 2022므15371, the Court held that a surrogacy agreement requiring a child conceived through assisted reproduction to be handed to intended parents was invalid under Article 103 of the Korean Civil Act. In the case before it, the woman had supplied the egg and carried and delivered the child; the Court treated her as the child’s mother. An agreement waiving the birth mother’s maternal rights was also invalid. The Court separately stated that, in exceptional circumstances, a parentage action may amount to an abuse of process if restoring the true family status would seriously harm the child’s welfare; it remanded the case for further consideration of that issue. This is a narrow, fact-specific litigation issue, not an exception validating the agreement. Do not assume the decision automatically resolves every gestational-carrier or donor-gamete scenario. Medical screening, consent forms or a clinic’s willingness to proceed do not, by themselves, make the arrangement legally valid. Before treatment or payment, obtain Korean legal advice based on the conception method, egg source, person who will carry and give birth, proposed agreement and parentage route.
Practical checklist before you commit
Before signing or paying, obtain: the clinic’s exact legal name and proof of designation; a written list of mandatory donor tests and any additional clinic tests; the screening results and the rule for communicating them; written confirmation of the egg donor’s retrieval history and spacing, including how the institution verifies the history and reports the result as required; all required consent forms in a language each signer understands; an itemised explanation of donor reimbursements and the approval/reporting process; the clinic’s written policy for adult-donor age and other acceptance criteria; and a separate written legal assessment of the proposed gestational-carrier procedure and intended parentage. Keep signed copies, test results, receipts, the proposed treatment plan and all communications. Ask the clinic to identify the legal basis for every condition it describes as mandatory.
If the clinic refuses a donor or patient
Ask for the reason in writing and identify whether it is based on a test result, a statutory restriction, the clinic’s own clinical policy, the patient’s status or the proposed surrogacy arrangement. If the reason is a health result, ask what rule applies, whether further medical review is possible and how the result was communicated. If the clinic cites a legal rule, request the exact article and current Korean text. If it cites internal policy, request the written policy and whether there is an internal review process. Do not try to bypass an adverse screening result, donor-history limit or consent requirement by changing clinics without disclosing relevant facts.
Three questions worth resolving early
Does a donor who passes the listed tests have no genetic risk? No. The statutory list includes general and infectious-disease screening, but it is not a guarantee against inherited conditions; ask separately about family history and any additional carrier testing. Does South Korean law set a single age range for every adult egg or sperm donor in the provisions discussed here? These provisions do not state a universal adult age range; a clinic may have a policy, which should be identified as such. Does the permitted reimbursement for a gamete donor prove that a surrogacy fee may be paid? No. Donor reimbursement is a limited statutory mechanism for specified items and cannot be treated as authorisation for a separate payment to a gestational carrier or intermediary.
A safe decision rule
Treat the legal minimum and the clinic’s treatment policy as separate checklists. Verify the institution’s designation, the donor’s required screening, the egg-retrieval limit and the institution’s history-check/reporting duties, written consent and forms, recordkeeping and the exact basis for every proposed payment. Then obtain a separate Korean legal opinion on the proposed surrogacy procedure and parentage pathway before making an irreversible payment or beginning treatment. The sources below are official Korean texts, but this article is not a final opinion on every possible procedure or the current practice of a particular clinic.
Official sources
- Article 22 — designation of embryo-producing medical institutions (생명윤리 및 안전에 관한 법률, 제22조(배아생성의료기관의 지정 등))
- Article 23 — requirements for embryo creation (생명윤리 및 안전에 관한 법률, 제23조(배아의 생성에 관한 준수사항))
- Article 24 — consent for embryo creation (생명윤리 및 안전에 관한 법률, 제24조(배아의 생성 등에 관한 동의))
- Article 27 — protection of gamete donors (생명윤리 및 안전에 관한 법률, 제27조(생식세포 기증자의 보호 등))
- Enforcement Rule, Article 20 — consent forms and records (생명윤리 및 안전에 관한 법률 시행규칙, 제20조(배아의 생성 등에 관한 동의))
- Enforcement Rule, Article 23 — screening criteria and result notification (생명윤리 및 안전에 관한 법률 시행규칙, 제23조 및 별표 2(생식세포 기증자 건강검진))
- Enforcement Decree, Article 11 — frequency of egg retrieval (생명윤리 및 안전에 관한 법률 시행령, 제11조(난자채취 빈도의 제한))
- Enforcement Rule, Article 24 — permitted donor reimbursement (생명윤리 및 안전에 관한 법률 시행규칙, 제24조(생식세포 기증자에 대한 실비보상))
- Enforcement Rule, Annex 2 — required gamete-donor screening tests (생명윤리 및 안전에 관한 법률 시행규칙 [별표 2] 생식세포 기증자의 건강검진 항목)
- Enforcement Rule, Article 23-2 — verification and reporting of egg-donor retrieval history (생명윤리 및 안전에 관한 법률 시행규칙 제23조의2(난자기증자에 대한 난자 채취 이력 확인 등))
- Supreme Court of Korea, 24 April 2025, Case 2022므15371 — surrogacy agreement and birth-mother status (대법원 2025. 4. 24. 선고 2022므15371 판결)
The official texts are in Korean; translations in this article are explanatory, not official translations.
